Navigation Links
Gene therapy slows progression of fatal neurodegenerative disease in children
Date:5/13/2008

New Rochelle, NY, May 13, 2008Gene therapy to replace the faulty CLN2 gene, which causes a neurodegenerative disease that is fatal by age 8-12 years, was able to slow significantly the rate of neurologic decline in treated children, according to a paper published online ahead of print in the May 2008 issue (Vol. 19 No. 5) of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc. The paper is available free online at www.liebertpub.com/hum

Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL) is an autosomal recessive genetic disorder that causes degeneration of the central nervous system. It is a form of Batten disease, a group of lysosomal storage disease in which a lipofuscin-like material is not broken down and accumulates in neurons, causing cognitive impairment, visual failure, seizures, and progressive deterioration of motor function.

Ronald Crystal and colleagues from Weill Cornell Medical College (New York, NY), describe a study conducted in 10 children with LINCL who received gene therapy to replace the defective CLN2 gene via administration of human CLN2 carried in an adeno-associated virus (AAV). In the paper entitled Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis with CNS Administration of a Serotype 2 Adeno-associated virus expressing the CLN2 cDNA, the authors report that over an 18-month period, assessment using a neurologic rating scale demonstrated significant slowing of disease progression in the treated, compared to the untreated children. On the basis of these findings, the authors proposed that additional studies to assess the safety and efficacy of AAV-mediated gene therapy for LINCL be pursued.

Although the treatment was associated with some serious adverse events in some patients, these were not unequivocally attributable to the gene therapy vector.

This clinical trial is an important step toward the development of treatments for this group of underserved i
'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

1

GOOD

Page: 1 2

Related biology news :

1. UC Davis stem researchers demonstrate safety of gene therapy using adult stem cells
2. Cell-based therapy shows promise in patients with Parkinsons disease
3. Cancer immunotherapy shows long-term promise in lung cancer
4. Effective cancer immune therapy through order in the blood vessels
5. New chemotherapy combo produces side effects, but no extra efficacy, in early breast cancer patients
6. Biomarkers allow doctors to match therapy to patient
7. MU researcher links hormone replacement therapy to breast cancer
8. Potential new target for multiple sclerosis therapy
9. Umbilical cord blood cell therapy may reduce signs and symptoms of Alzheimers disease
10. Umbilical cord blood cell therapy in an animal model of Alzheimers disease
11. Tumor-targeting viral therapy slows neuroblastoma, malignant peripheral nerve sheath tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)...from heart attacks. But to do that they have to pr...arlier this year, a team led by William Maisel at ...al radio transmitter could be used to modify wirel...t, 22 March, p 23). Doctors normally use these si...but a malicious hacker could reprogram the pacemak...
(Date:8/20/2008)... (CAMH) is proud to announce a landmark investment...ation (CFI) into research that will propel the und... of mental illness and addiction to the next level...cale Institutional Endeavours component of CFI,s R...our scientific strengths, and transform lives with...
(Date:8/20/2008)...ve found a way to convert ethanol and other biofue...yst makes hydrogen from ethanol with 90 percent yi...ive ingredients. , Umit Ozkan, professor of chem...iversity, said that the new catalyst is much less ...orld, because it does not contain precious metals,...
(Date:8/19/2008)...oring bran flakes; it can also preserve important ...Institute of Standards and Technology (NIST) have ... for evaluating the sugars pharmaceutical companie...om temperature. The group presented their findings...Meeting and Exposition. , Protein-based drugs su...
Breaking Biology News(10 mins):How to stop a new type of heart attack 2Large-scale investment catapults CAMH's mental illness and addiction research forward 2A better way to make hydrogen from biofuels 2A better way to make hydrogen from biofuels 3Candy-coating keeps proteins sweet 2Vaccine for Ebola virus 2664 1Vaccine for Ebola virus 2664 2Increased Heart Risk Seen for Retired NFL Players 15469 1Increased Heart Risk Seen for Retired NFL Players 15469 2Major international collaboration offers new clues to genetics of type 2 diabetes 2662 1Major international collaboration offers new clues to genetics of type 2 diabetes 2662 2Major international collaboration offers new clues to genetics of type 2 diabetes 2662 3Comparison of anticoagulants for angioplasty show similar outcomes 15466 1Comparison of anticoagulants for angioplasty show similar outcomes 15466 2
...shows that statins, which are typically used as an...ation of the hepatitis C virus (HCV). They could r...feron. These findings are published in the July 20...e American Association for the Study of Liver Dise...Inc., Hepatology is available online via Wiley Int...
...uard turned traitor, a protein whose regular job i...me cases, join forces with another protein to do t... new research at the University of Minnesota. The ...damage, for example, from ultraviolet light, and a... can become dysfunctional or cancerous. The protei...
...hers report that thousands of genes behave differe...thing never detected to this degree. Published in...eds light on why the same disease often strikes ma...ay respond differently to the same drug. , "We pr...s vary in their relationship to different diseases...
...artment of Energy (DOE) today released an ambitiou...losic ethanol as an alternative to gasoline. The ...s in biotechnology that have made cost-effective p...lant fiber, an attainable goal. The report outlin...hnologies to transform cellulosic ethanol--a renew...
Other Biology News:Statins stop hepatitis C virus from replicating 2University of Minnesota researchers take new look at cellular suicide 2UCLA study finds same genes act differently in males and females 2UCLA study finds same genes act differently in males and females 3DOE publishes research roadmap for developing cleaner fuels 2
(Date:8/21/2008)... NEW YORK, MUNICH, Germany and AMSTERDAM, Neth...thcare and SpePharm Holding, B.V., the,pan-Europea...d that they,have entered into a euro 10 million re...fund SpePharm,s acquisition of Dantrium(R) for Eur...le Pharmaceuticals. At the same,time, TVM Capital,...
(Date:8/20/2008)... VIENNA, Va., Aug. 20 /PRNewswire-USNewswire/ ...0 ranking of the fastest-growing private companies...T) services provider,MicroTech, ranks No. 285 on ... 2008 Inc. 500 list measures revenue growth from 2...U.S.-based, privately held, independent -,no subsi...
(Date:8/20/2008)... INDIANAPOLIS, Ind., Aug. 20 /PRNewswire-First... announced that it has completed the acquisition,o...n Diego-based,biotechnology company focused on dru...y. The completion of the deal followed today,s Spe...SGX stockholders voted in,favor of the merger agre...
(Date:8/20/2008)... Growth Fueled by Popularity with Seniors and ... Marketing, CAMBRIDGE, Mass., Aug. 20 /PRNewswi...hole Health (SWH), a voluntary health care plan fo...ng private company in the,United States., Part of...rowing,companies, SWH had revenue growth of 31,000...
Breaking Biology Technology:TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 2TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 3TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 4TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 5MicroTech Ranks No. 285 on Inc. Magazine's 2008 List of the 500 Fastest Growing Private Companies in America 2Lilly Announces Completion of SGX Acquisition 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 3
... about the size and growth of the medical device i...week,s column will focus on the leading players in...mment on some trends from this table, here are a c... here is the major part of the diagnostics busines...h includes clinical and molecular diagnostics. Thi...
La Crosse, Wis. - Firstlogic, Inc., announced today an expansion of its OEM partnership with Informatica Corp. of Redwood City, Calif., involving Firstlogic,s Data Quality Link for Informatica. , ,
...tics, Inc., has become is the first seed lab in th...ccredited Seed Lab (ASL) program, administered by...), the company reported Tuesday. , , BioDiagnostic...n testing services. , ,The ASL Program is a volun...aboratories. Seed testing laboratories, which meet...
...stems, Inc. has received FDA approval to market i...nced Tuesday. It will start marketing the system d... intended to monitor physiological parameters of p...ign allows a variety of optional configurations th... around the world. , ,Criticare designs, manufactu...
Other Biology Technology:Midwest plays key role in developing new medical device companies 2Midwest plays key role in developing new medical device companies 3
SAIVI Alexa Fluor 680 injectable contrast agent *bovine serum albumin*
RABBIT ANTI QUINOLINIC ACID
All MagCellect Ferrofluid products perform optimally when used in conjunction with R&D Systems MagCellect Magnet. To accommodate different processing capacities, this neodymium iron boron permanent m
Form: Concentrated Applications: ELISA
Biology Products: